about
Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy geneGenomic characterization of recent human LINE-1 insertions: evidence supporting random insertionPhysical Activity and Lymphedema (the PAL trial): assessing the safety of progressive strength training in breast cancer survivorsRegression modeling of longitudinal data with outcome-dependent observation times: extensions and comparative evaluation.Comparison of administrative/billing data to expected protocol-mandated chemotherapy exposure in children with acute myeloid leukemia: A report from the Children's Oncology Group.Pseudo-likelihood methods for longitudinal binary data with non-ignorable missing responses and covariates.A comparative analysis of quality of life data from a Southwest Oncology Group randomized trial of advanced colorectal cancer.Phase II study of topotecan and paclitaxel for recurrent, persistent, or metastatic cervical carcinoma.A test of financial incentives to improve warfarin adherenceA phase I/II trial of hydroxychloroquine in conjunction with radiation therapy and concurrent and adjuvant temozolomide in patients with newly diagnosed glioblastoma multiforme.A weighted combination of pseudo-likelihood estimators for longitudinal binary data subject to non-ignorable non-monotone missingness.The cutaneous lupus erythematosus disease area and severity index: a responsive instrument to measure activity and damage in patients with cutaneous lupus erythematosus.Comparison of the reliability and validity of outcome instruments for cutaneous dermatomyositisDetection of Therapeutically Targetable Driver and Resistance Mutations in Lung Cancer Patients by Next-Generation Sequencing of Cell-Free Circulating Tumor DNATranslating the hemoglobin A1C with more easily understood feedback: a randomized controlled trial.A bivariate pseudolikelihood for incomplete longitudinal binary data with nonignorable nonmonotone missingnessThe risk of stroke in patients with psoriasisReliability, validity and responsiveness to change of the Patient Report of Extent of Psoriasis Involvement (PREPI) for measuring body surface area affected by psoriasisEffect of Financial Incentives to Physicians, Patients, or Both on Lipid Levels: A Randomized Clinical Trial.Patients with severe psoriasis are at increased risk of cardiovascular mortality: cohort study using the General Practice Research Database.Oral curcumin in the treatment of moderate to severe psoriasis vulgaris: A prospective clinical trial.The risk of depression, anxiety, and suicidality in patients with psoriasis: a population-based cohort study.Palmoplantar psoriasis is associated with greater impairment of health-related quality of life compared with moderate to severe plaque psoriasisPatient-reported outcomes for psoriasis patients with clear versus almost clear skin in the clinical setting.Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K.A transition model for quality-of-life data with non-ignorable non-monotone missing data.Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanomaCombined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.Reliability and convergent validity of two outcome instruments for pemphigus.Premium-Based Financial Incentives Did Not Promote Workplace Weight Loss In A 2013-15 Study.Effect of genetic counseling and testing for BRCA1 and BRCA2 mutations in African American women: a randomized trial.A randomized, controlled trial of financial incentives for smoking cessation.Major cardiovascular events associated with anti-IL 12/23 agents: a tale of two meta-analyses.Validity of The Health Improvement Network (THIN) for the study of psoriasis.Comparative effectiveness of less commonly used systemic monotherapies and common combination therapies for moderate to severe psoriasis in the clinical settingThe risk of infection and malignancy with tumor necrosis factor antagonists in adults with psoriatic disease: a systematic review and meta-analysis of randomized controlled trials.Weight lifting in women with breast-cancer-related lymphedema.Patient satisfaction with treatments for moderate-to-severe plaque psoriasis in clinical practiceFinancial incentives for extended weight loss: a randomized, controlled trial.Psychosocial encounters correlates with higher patient-reported functional quality of life in gynecological cancer patients receiving radiotherapy.
P50
Q24617547-1F2FFA2C-8F90-4B9A-8D9C-76A60CEAC552Q28776429-1C1D788C-ABAA-43B2-9D80-AF7318FD69C8Q30489696-C11A44FF-2602-47FB-8D9D-692B68860BBFQ30838005-801E5DDE-D198-4160-B9CC-B944B4346EE5Q30908480-F16054DD-D1C5-4C94-9619-5EB7E0142C7AQ31025276-E8FF31FB-719F-42BA-88A9-6734B0259645Q32067189-4946B8F6-47D0-4E2D-8698-8B71297700C3Q33358885-B62A5A4E-5C56-4492-A4B9-B9AA8B99D48BQ33395146-14341227-23B3-444A-B3EE-54234D636BF5Q33416266-FD42AD5B-2B43-46CF-9037-1B13E4035EA7Q33537299-FAE06982-0A9E-4A20-A054-2819F98FC9CAQ33692647-49B4B12E-8387-4342-ACE1-EC1A029DBE7FQ33692655-201D0A82-1CA3-421E-9221-B93606BCA773Q33737740-D950CE8D-4F6D-41AE-8410-CB8247671799Q33770238-FE5410A3-A1F7-4187-83D1-6C39A2361832Q33771065-19A8D85C-4BEB-4328-A8BC-E9D97D936216Q33831094-59CD430B-39B0-4D3C-A595-1D7DF5DB6373Q33879351-C07229D8-FECE-48DA-B727-E207AA7398DCQ33902510-60C500F2-56EF-436D-973F-8C5E5AEF7CC9Q33951592-22496607-35F9-4964-9C89-0D33605B4733Q34038554-36B7F1C0-FCEB-4364-ACF5-BC63CCD3705EQ34083409-09876E2A-BA4D-4400-B9C6-B4D18A386BD5Q34194956-0E96A07E-D929-45D8-AFFF-5F68F40115F8Q34196035-1F5CCDAA-9B48-47BE-A757-3553681A3AA9Q34253312-D831A555-426C-4F53-88CE-41717367D8B4Q34349118-CD2DD71B-E1DF-4A18-A9EA-2517923E2FBCQ34372972-4B2E9965-5D38-4E64-BBC4-622B071EF3E9Q34372987-15321BC7-4EAD-4791-8795-4800FF770131Q34441185-4F68C00E-61B3-4190-8335-42210DBBF781Q34507485-6A9D340A-D86F-4F1A-AC44-0841361A357EQ34515660-225CC01D-70A3-4A5E-92C0-A84659D4047BQ34604539-8C096DB1-DFA3-4BFF-A8BF-14FCD40163D3Q34678706-8355259E-E769-41B9-8CDC-D60AEBF7BF05Q34721703-A15E8E29-6571-46CA-BB78-2B77EB8556B8Q34743112-944846A5-7630-40D9-894D-3F06896F406AQ34984568-B82AF9FB-994F-40A7-833B-B834193DA14FQ34997043-C179520E-0A94-498C-9DF9-FAAF4FBFE390Q34997467-47B9457E-F9F6-4D5A-88B9-060D7EE90F89Q35007004-DF5D8C87-7CAB-4CBD-9346-A917DED8ED3FQ35096479-39E6B381-5FEB-4FB3-B178-7B659A57662C
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Andrea B Troxel
@ast
Andrea B Troxel
@en
Andrea B Troxel
@es
Andrea B Troxel
@nl
type
label
Andrea B Troxel
@ast
Andrea B Troxel
@en
Andrea B Troxel
@es
Andrea B Troxel
@nl
prefLabel
Andrea B Troxel
@ast
Andrea B Troxel
@en
Andrea B Troxel
@es
Andrea B Troxel
@nl
P106
P31
P496
0000-0002-1393-3075